Trial intelligence / Profile preview

Safety of BAY 987519 sunscreen in sport users

NCT02857478Completed

Sponsor
Bayer
Start
Jun 2015
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of BAY 987519 in sunburn, sponsored by Bayer. Primary endpoints: Evaluation of Erythema at 24 hours and Evaluation of Adverse Events at 24 hours. Started Jun 2015; status: completed.

02

Drugs

BAY 987519
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02857478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02857478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call